Obstructive Cardiomyopathy, Hypertrophic research hub

A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

This study is looking at a new medication, sotagliflozin, to see if it can help people with a heart condition called hypertrophic cardiomyopathy (HCM). It aims to find out if the drug improves symptoms and daily activities compared to a dummy pill.